vTv Therapeutics Inc. SEC filings VTVT
vTv Therapeutics Inc. has 601 filings in SEC EDGAR's recent list, going back to May 14, 2015. Its latest annual report, Form 10-K, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 8, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 6, 2026 | Oct 1, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2026 | — |
| 4 | Insider transaction | Jun 29, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 29, 2026 | Jun 26, 2026 |
| DEFA14A | Additional proxy material | Jun 10, 2026 | — |
| 424B2 | Prospectus | May 13, 2026 | — |
| 8-K |
Current report
Other events
|
May 13, 2026 | May 13, 2026 |
| S-8 | Employee stock plan registration | May 13, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 16, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 27, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 10-K | Annual report | Mar 10, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Material agreement
|
Feb 2, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 19, 2025 | Dec 19, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 9, 2025 | — |
| EFFECT | Filing | Nov 24, 2025 | — |
| CORRESP | Letter to the SEC | Nov 20, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| S-3 | Shelf registration | Oct 3, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 25, 2025 | — |
| 4 | Insider transaction | Sep 25, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 10, 2025 | Sep 10, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 8, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 8, 2025 | — |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 3, 2025 | — |
| 8-K |
Current report
Material agreement
|
Sep 2, 2025 | Aug 29, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | May 21, 2025 | May 19, 2025 |
| 3 | Initial insider ownership | May 21, 2025 | May 19, 2025 |
| 8-K |
Current report
Officer or director change
|
May 19, 2025 | May 19, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 16, 2025 | May 16, 2025 |
| 8-K |
Current report
Results of operations
|
May 15, 2025 | May 15, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 144 | Notice of proposed sale | May 1, 2025 | — |
| 144 | Notice of proposed sale | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Apr 24, 2025 | Jun 25, 2024 |
| 144 | Notice of proposed sale | Apr 24, 2025 | — |
| 3 | Initial insider ownership | Apr 11, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 11, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 31, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Other events
|
Mar 17, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 1, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 27, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Dec 6, 2024 | Mar 5, 2024 |
| 4 | Insider transaction | Dec 6, 2024 | Mar 5, 2024 |
| 4 | Insider transaction | Nov 19, 2024 | Nov 15, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| 8-K |
Current report
Agreement ended
|
Oct 25, 2024 | Oct 22, 2024 |
| S-8 | Employee stock plan registration | Sep 23, 2024 | — |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Jul 26, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Material agreement
|
Jul 2, 2024 | Jun 26, 2024 |
| 4 | Insider transaction | Jun 27, 2024 | Jun 25, 2024 |
| 4 | Insider transaction | Jun 27, 2024 | Jun 25, 2024 |
| 4 | Insider transaction | Jun 27, 2024 | Jun 25, 2024 |
| 4 | Insider transaction | Jun 27, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Mar 13, 2024 |
| 3 | Initial insider ownership | Jun 13, 2024 | Jun 11, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| EFFECT | Filing | Apr 29, 2024 | — |
| 424B2 | Prospectus | Apr 29, 2024 | — |
| 424B2 | Prospectus | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 11, 2024 |
| UPLOAD | Letter from the SEC | Apr 16, 2024 | — |
| S-3 | Shelf registration | Apr 10, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 26, 2024 | Mar 25, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 22, 2024 | — |
| 3 | Initial insider ownership | Mar 14, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 14, 2024 | Mar 13, 2024 |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Mar 7, 2024 | Mar 5, 2024 |
| 3 | Initial insider ownership | Mar 7, 2024 | Feb 27, 2024 |
| 3 | Initial insider ownership | Mar 7, 2024 | Feb 27, 2024 |
| D | Filing | Mar 7, 2024 | — |
| SC 13D | Ownership over 5% (active) | Mar 5, 2024 | — |
| SC 13D | Ownership over 5% (active) | Mar 5, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2024 | Mar 5, 2024 |
| 3 | Initial insider ownership | Feb 29, 2024 | Feb 27, 2024 |
| 4 | Insider transaction | Feb 29, 2024 | Feb 27, 2024 |
| 3 | Initial insider ownership | Feb 29, 2024 | Feb 23, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Feb 28, 2024 | Feb 28, 2024 |
| 424B5 | Prospectus supplement | Feb 28, 2024 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Feb 28, 2024 | Feb 23, 2024 |
| 8-K |
Current report
Agreement ended, Officer or director change
|
Dec 22, 2023 | Dec 18, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 19, 2023 | Dec 13, 2023 |
| 8-K |
Current report
Other events
|
Dec 12, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Other events
|
Nov 20, 2023 | Nov 20, 2023 |
| 8-K |
Current report
Other events
|
Nov 15, 2023 | Nov 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 15, 2023 | Nov 15, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K | Current report | Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Other events
|
Nov 1, 2023 | Oct 30, 2023 |
| DEF 14C | Information statement | Sep 25, 2023 | Sep 25, 2023 |
| PRE 14C | Filing | Sep 15, 2023 | Sep 11, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 20, 2023 | Jul 17, 2023 |
| 8-K |
Current report
Listing notice
|
Jun 26, 2023 | Jun 21, 2023 |
| 4/A | Form 4/a | Jun 21, 2023 | Aug 17, 2022 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 19, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 19, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 19, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 19, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 19, 2023 |
| 4 | Insider transaction | Jun 21, 2023 | Jun 19, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 8, 2023 | Jun 6, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2023 | — |
| 10-K | Annual report | Mar 6, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 6, 2023 | Mar 6, 2023 |
| 3 | Initial insider ownership | Mar 6, 2023 | Mar 29, 2022 |
| 8-K |
Current report
Other events
|
Feb 1, 2023 | Feb 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2023 | Jan 6, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 23, 2022 | Dec 22, 2022 |
| 4 | Insider transaction | Dec 13, 2022 | Dec 12, 2022 |
| 3 | Initial insider ownership | Dec 13, 2022 | Dec 8, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 13, 2022 | Dec 8, 2022 |
| 4 | Insider transaction | Nov 30, 2022 | Nov 28, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| SC 13G | Ownership over 5% (passive) | Aug 23, 2022 | — |
| 4 | Insider transaction | Aug 18, 2022 | Aug 17, 2022 |
| 3 | Initial insider ownership | Aug 18, 2022 | Aug 9, 2022 |
| 4 | Insider transaction | Aug 17, 2022 | Jul 13, 2022 |
| 3 | Initial insider ownership | Aug 17, 2022 | Jul 11, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 15, 2022 | Aug 9, 2022 |
| 3 | Initial insider ownership | Aug 8, 2022 | Aug 1, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2022 | Jul 25, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 25, 2022 | Jul 22, 2022 |
| 4 | Insider transaction | Jul 15, 2022 | Jul 13, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 15, 2022 | Jul 11, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 4 | Insider transaction | Jul 6, 2022 | Jul 1, 2022 |
| 3 | Initial insider ownership | Jun 23, 2022 | May 31, 2022 |
| 3 | Initial insider ownership | Jun 10, 2022 | May 31, 2022 |
| SC 13D | Ownership over 5% (active) | Jun 10, 2022 | — |
| 3 | Initial insider ownership | Jun 10, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2022 | Jun 1, 2022 |
| SC 13D/A | Amended ownership over 5% (active) | Jun 1, 2022 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 1, 2022 | May 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 15, 2022 | Apr 15, 2022 |
| 10-K/A | Amended annual report | Apr 5, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 5, 2022 | Mar 30, 2022 |
| 10-K | Annual report | Mar 29, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2022 | Mar 29, 2022 |
| 4 | Insider transaction | Mar 4, 2022 | Mar 3, 2022 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change
|
Mar 3, 2022 | Feb 27, 2022 |
| 8-K |
Current report
Listing notice
|
Feb 18, 2022 | Feb 17, 2022 |
| 4 | Insider transaction | Dec 21, 2021 | Dec 20, 2021 |
| 8-K |
Current report
Other events
|
Dec 7, 2021 | Dec 6, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VTVT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- High Point, NC
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1641489
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.